What's new? Log in Free sign up

Filing search / Cartesian Therapeutics, Inc. / "Society"

Search information

Cartesian Therapeutics, Inc.

Companies

"Society"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

35 results

Newest first Best match first

RNAC Cartesian Therapeutics, Inc.

Regulation FD Disclosure

were subsequently featured during an oral session at the American Society of Gene and Cell Therapy 27th Annual Meeting in May 2024. Conference Call

RNAC Cartesian Therapeutics, Inc.

Cartesian Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

, including JDM. Safety and Tolerability Data to be Featured at 66th American Society of Hematology (ASH) Annual Meeting and Exposition. In November 2024 … at the upcoming 66th American Society of Hematology (ASH) Annual Meeting and Exposition, being held December 7-10, 2024, in San Diego. Descartes-15 Program

RNAC Cartesian Therapeutics, Inc.

Prospectus with selling stockholder info

of Immunologists Meritorious Career Award, the Stratton Medal from the American Society of Hematology, and the Basic Research Prize from the American … Engineering and the Biomedical Engineering Society. Dr. Jewell completed his Ph.D. in Chemical Engineering at the University of Wisconsin

RNAC Cartesian Therapeutics, Inc.

IPO registration (amended)

, the Stratton Medal from the American Society of Hematology, and the Basic Research Prize from the American Heart Association. In 2022, Dr. Springer received … professional awards and is an elected Fellow of the American Institute for Medical and Biological Engineering and the Biomedical Engineering Society

20 Sep 24

4:17pm

RNAC Cartesian Therapeutics, Inc.

IPO registration (amended)

Meritorious Career Award, the Stratton Medal from the American Society of Hematology, and the Basic Research Prize from the American Heart Association … and the Biomedical Engineering Society. Dr. Jewell completed his Ph.D. in Chemical Engineering at the University of Wisconsin and was a Ragon Postdoctoral Fellow

9 Sep 24

4:11pm

IPO registration

2 Aug 24

7:34am

Cartesian Therapeutics Announces $130 Million Private Placement Equity Financing

Cartesian Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Definitive proxy

26 Apr 24

9:09am

Definitive proxy

14 Feb 24

4:42pm

Additional proxy soliciting materials

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

asttrg4yfd 5bjir7i4

Definitive proxy

28 Apr 23

12:00am

Preliminary proxy

18 Apr 23

4:34pm

Selecta Biosciences Reports Third Quarter 2022 Financial Results

fdbchebvhv981 cmprz

Selecta Biosciences Reports Second Quarter 2022 Financial Results

xivsv6dzz vylqkfd

Definitive proxy

3 May 22

8:25am

mcdyjqz1o6tefb k5fo

Annual report (amended)

Prev
1
2
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.